Peptide-guided nanoparticles for glioblastoma targeting
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 308, 109-118
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Israel Science Foundation
- Eesti Teadusagentuur
- Norway Grants
- EMBO
- European Research Council
This publication has 52 references indexed in Scilit:
- p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding abilityNucleic Acids Research, 2012
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastomaProceedings of the National Academy of Sciences, 2011
- Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient miceProceedings of the National Academy of Sciences, 2011
- Transdifferentiation of glioblastoma cells into vascular endothelial cellsProceedings of the National Academy of Sciences, 2011
- Cooperative nanomaterial system to sensitize, target, and treat tumorsProceedings of the National Academy of Sciences, 2009
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into TumorsCancer Cell, 2009
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProceedings of the National Academy of Sciences, 2009
- Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor TargetingSmall, 2009
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Development of a novel mouse glioma model using lentiviral vectorsNature Medicine, 2009